Expression of Connective Tissue Growth Factor after Glaucoma Filtration Surgery in a Rabbit Model

Investigative Ophthalmology and Visual Science

Volumn 45, Issue 2, 2004, Pages 485-491

  Esson, Douglas W ^a   Neelakantan, Arvind ^a   Iyer, Sandhya A ^a   Blalock, Timothy D ^b   Balasubramanian, Lakshmi ^b   Grotendorst, Gary R ^c   Schultz, Gregory S ^a,b   Sherwood, Mark B ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; MITOMYCIN C; SODIUM CHLORIDE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GLAUCOMA; GLAUCOMA DRAINAGE IMPLANT; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; SCAR FORMATION; WOUND CONTRACTION;

ANIMALS; CONJUNCTIVA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FILTERING SURGERY; GLAUCOMA; IMMEDIATE-EARLY PROTEINS; IMMUNOHISTOCHEMISTRY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MODELS, ANIMAL; RABBITS; TRABECULAR MESHWORK; TRANSFORMING GROWTH FACTOR BETA;

EID: 0942265583     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.03-0485     Document Type: Article

References (50)

1. Addicks EM, Quigley A, Green WR, Robin AL. Histologic characteristics of filtering blebs in glaucomatous eyes. Arch Ophthalmol. 1983;101:795-798.
2. Hitchings RA, Grierson I. Clinico pathological correlation in eyes with failed fistulizing surgery. Trans Ophthalmol Soc UK. 1983;103:84-88.
3. Fuller JR, Bevin TH, Molteno ABC, Vote BJT, Herbison P. Antiintlammatory fibrosis suppression in threatened trabeculectomy bleb failure produces good long term control of intraocular pressure without risk of sight threatening complications. Br J Ophthalmol 2002;86:1352-1354.
4. Levine JH, Moses HL, Gold LI, Nanney LB. Spatial and temporal patterns of immunoreactive transforming growth factor-beta-1, -beta-2 and -beta-3 during excisional wound repair. Am J Pathol. 1993;143:368-380.
5. Connor TB, Roberts AB, Sporn MB, et al. Correlation of fibrosis and transforming growth factor-beta type 2 levels in the eye. J Clin Invest. 1989;83:1661-1666.
6. Pasquale LR, Dorman Pease ME, Lutty GA, Quigley HA, Jampel HD. Immunolocalisation of TGF-beta1, TGF-beta2 and TGF-beta3 in the anterior segment of the human eye. Invest Ophthalmol Vis Sci. 1993;34:23-30.
7. Khaw PT Occleston NL, Schultz G, Grierson I, Sherwood MB, Larkin G. Activation and suppression of fibroblast function. Eye. 1994;8:188-195.
8. Kay EP, Lee HK, Park KS, Lee SC. Indirect mitogenic effect of transforming growth factor-beta on cell proliferation of subconjunctival fibroblasts. Invest Ophthalmol Vis Sci. 1998;39:481-486.
9. Lutty GA, Merges C, Threlkeld AB, Crone S, Mcleod DS. Heterogeneity in localization of isoforms of TGF-beta in human retina, vitreous and choroid. Invest Ophthalmol Vis Sci. 1993;34:477-487.
10. Pena RA, Jerdan JA, Glaser BM. Effects of TGF-beta and TGF-beta neutralizing antibodies on fibroblast-induced collagen gel contraction: implications for proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci. 1994;35:2804-2808.
11. Parekh T, Saxena B, Reibman J, Cronstein BN, Gold LI. Neutrophil chemotaxis in response to TGF-beta isoforms (TGF-beta 1, TGF-beta 2, TGF-beta 3) is mediated by fibronectin. J Immunol. 1994;152:2456-2466.
12. Wahl SM, Hunt DA, Wakefield LM, et al. Transforming growth factor type beta induces monocyte chemotaxis and growth factor production. Proc Natl Acad Sci USA. 1987;84:5788-5792.
13. Cordeiro M, Bhattacharya S, Schultz G, et al. TGF-β1, -β2 and -β3 in vitro: biphasic effects on Tenon's fibroblast contraction, proliferation and migration. Invest Ophthalmol Vis Sci. 2000;41:756-763.
14. Connor T, Roberts A, Sporn M, et al. Correlation of fibrosis and transforming growth factor-beta type 2 levels in the eye. J Clin Invest. 1989;83:1661-1666.
15. Jampel H, Roche N, Stark W, et al. Transforming growth factor-beta in human aqueous humor. Curr Eye Res. 1990;9:963-969.
16. Cordeiro MF, Mead A, Ali RR, et al. Novel antisense oligonucleotides targeting TGF-beta inhibit in vivo scarring and improve surgical outcome. Gene Ther. 2003;10:59-71.
17. Cordeiro MF, Gay JA, Khaw PT. Human anti-transforming growth factor-beta2 antibody: a new glaucoma anti-scarring agent. Invest Ophthalmol Vis Sci. 1999;40:2225-2234.
18. Grainger DJ, Wakefield L, Bethell HW, Farndale RW, Metcalfe JC. Release and activation of platelet latent TGF-beta in blood clots during dissolution with plasmin. Nat Med. 1995;1:932-937.
19. Schultz-Cherry S, Chen H, Mosher DF, et al. Regulation of transforming growth factor-beta activation by discrete sequences of thrombospondin 1. J Biol Chem. 1995;270:7304-7310.
20. Joseph JP, Grierson I, Hitchings RA. Normal rabbit aqueous humour, fibronectin, and fibroblast conditioned medium are chemoattractant to Tenon's capsule fibroblasts. Eye. 1987;1:585-592.
21. Burke J, Foster S, Herschler J. Aqueous humor as a modulator of growth in fibroblast cultures. Curr Eye Res. 1982;2:835-841.
22. Abreu JG Ketpura NI, Reversade B, De Robertis EM. Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-beta. Nat Cell Biol. 2002;4:599-604.
23. Frazier K, Williams S, Kothapalli D, Klapper H, Grotendorst GR. Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor. J Invest Dermatol. 1996;107:404-411.
24. Pelton RW, Hogan BL, Miller DA, Moses HL. Differential expression of genes encoding TGFs beta 1, beta 2, and beta 3 during murine palate formation. Dev Biol. 1990;141:456-460.
25. Igarashi A, Okochi H, Bradham DM, Grotendorst GR. Regulation of connective tissue growth factor gene expression in human skin fibroblasts and during wound repair. Mol Biol Cell. 1993;4:637-645.
26. Kothapalli D, Frazier KS, Welply A, Segarini PR, Grotendorst GR. Transforming growth factor beta induces anchorage-independent growth of NRK fibroblasts via a connective tissue growth factor-dependent signaling pathway. Cell Growth Differ. 1997;8:61-68.
27. Kucich U, Rosenbloom JC, Herrick DJ, et al. Signaling events required for transforming growth factor-beta stimulation of connective tissue growth factor expression by cultured human lung fibroblasts. Arch Biochem Biophys. 2001;395:103-112.
28. Leask A, Holmes A, Black CM, Abraham DJ. Connective tissue growth factor gene regulation: requirements for its induction by transforming growth factor-beta 2 in fibroblasts. J Biol Chem. 2003;278:13008-13015.
29. Duncan MR, Frazier KS, Abramson S, et al. Connective tissue growth factor mediates transforming growth factor beta-induced collagen synthesis: down-regulation by cAMP. FASEB J. 1999;13:1774-1786.
30. Grotendorst GR. Connective tissue growth factor: a mediator of TGF-beta action on fibroblasts (review). Cytokine Growth Factor Rev. 1997;8:171-179.
31. Ihn H. Pathogenesis of fibrosis: role of TGF-beta and CTGF. Curr Opin Rheumatol. 2002;14:681-685.
32. Miller MH, Grierson I, Unger WI, Hitchings RA. Wound healing in an animal model of glaucoma fistulizing surgery. Ophthalmic Surg. 1989;20:350-357.
33. Robin AL, Ramakrishnan R, Krishnadas R, et al. A long-term doseresponse study of mitomycin in glaucoma filtration surgery. Arch Ophthalmol. 1997;115:969-974.
34. Cordeiro MF, Constable PH, Alexander RA, et al. Effect of varying the mitomycin-C treatment area in glaucoma filtration surgery in the rabbit. Invest Ophthalmol Vis Sci. 1997;38:1639-1646.
35. Stamper RL, McMenemy MG, Lieberman MF. Hypotonous maculopathy after trabeculectomy with subconjunctival 5-fluorouracil. Am J Ophthalmol. 1992;114:544-553.
36. Parrish R, Minckler D. "Late endophthalmitis": filtering surgery time bomb (editorial)? Ophthalmology. 1996;103:1167-1168.
37. Jampel HD, Pasquale LR, Dibernardo C. Hypotony maculopathy following trabeculectomy with mitomycin C (letter). Arch Ophthalmol. 1992;110:1049-1050.
38. Kangas TA, Greenfield DS, Flynn HW, Parrish RK II, Palmberg PSO. Delayed-onset endophthalmitis associated with conjunctival filtering blebs. Ophthalmology. 1997;104:746-752.
39. Greenfield DS, Liebmann JM, Jee J, Ritch R. Late-onset bleb leaks after glaucoma filtering surgery. Arch Ophthalmol. 1998;116:443-447.
40. Mietz H, Addicks K, Bloch W, Krieglstein GKSO. Long-term intraocular toxic effects of topical mitomycin C in rabbits. J Glaucoma. 1996;5:325-333.
41. Wolner B LiebmannJM, Sassani JW et al. Late bleb-related endophthalmitis after trabeculectomy with adjunctive 5-fluorouracil. Ophthalmology. 1991;98:1053-1060.
42. Brown RH, Yang LH, Walker SD, et al. Treatment of bleb infection after glaucoma surgery. Arch Ophthalmol. 1994;112:57-61.
43. Waheed S, Liebmann JM, Greenfield DS, et al. Recurrent bleb infections. Br J Ophthalmol. 1998;82:926-929.
44. Soltau JB, Rothman RF, Budenz DL, et al. Risk factors for glaucoma filtering bleb infections. Arch Ophthalmol. 2000;118:338-342.
45. Greenfield DS, Liebmann JM, Jee J, et al. Late-onset bleb leaks after glaucoma filtering surgery. Arch Ophthalmol. 1998;116:443-447.
46. Igarashi A, Nashiro K, Kikuchi K, et al. Significant correlation between connective tissue growth factor gene expression and skin sclerosis in tissue sections from patients with systemic sclerosis. J Invest Dermatol. 1995;105:280-284.
47. Oemar BS, Werner A, Garnier JM, et al. Human connective tissue growth factor is expressed in advanced atherosclerotic lesions. Circulation. 1997;95:831-839.
48. Dammeier J, Brauchle M, Falk W, Grotendorst GR, Werner S. Connective tissue growth factor: a novel regulator of mucosal repair and fibrosis in inflammatory bowel disease? Int J Biochem Cell Biol. 1998;30:909-922.
49. Wunderlich K, Senn BC, Reiser P, Pech M, Flammer J, Meyer P. Connective tissue growth factor in retrocorneal membranes and corneal scars. Ophthalmologica. 2000;214:341-346.
50. Khaw PT, Occleston NL, Schultz GS, Grierson I, Sherwood MB, Larkin G. Activation and suppression of fibroblast function. Eye. 1994;8:188-195.